NeuroThera Labs validates quantum sampling workflow for clinical trial data analytics platform

• NeuroThera Labs completed internal validation of a proprietary quantum sampling workflow for clinical trials data analytics.
• Workflow represents continuous probability distributions in a quantum framework, supporting Quantum Markov Chain Monte Carlo sampling with classical acceptance.
• Implementation was built and tested on a hybrid quantum-classical computing platform operated by an unnamed S&P 500 company.
• Company expects the validated component to expand its platform’s ability to analyze large-scale clinical and biomedical datasets.
• Platform development runs through CliniQuantum, a quantum technology initiative in which NeuroThera holds a 54.01% stake.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurothera Labs Inc. published the original content used to generate this news brief via TheNewswire (Ref. ID: 202607290805TNWSWRCACNPR_____1AdyFmo2X) on July 29, 2026, and is solely responsible for the information contained therein.